![Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy - ScienceDirect Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525157818305956-gr1.jpg)
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy - ScienceDirect
Homozygous mutations in NTRK1 gene underlie congenital insensitivity to pain with anhidrosis in Pakistani families
![e Genomic characterization of TPM3-NTRK1 fusion in KM12 cell line A)... | Download Scientific Diagram e Genomic characterization of TPM3-NTRK1 fusion in KM12 cell line A)... | Download Scientific Diagram](https://www.researchgate.net/publication/263085946/figure/fig2/AS:614198736338944@1523447798152/e-Genomic-characterization-of-TPM3-NTRK1-fusion-in-KM12-cell-line-A-End-point-PCR-was.png)
e Genomic characterization of TPM3-NTRK1 fusion in KM12 cell line A)... | Download Scientific Diagram
![PDF] Refractory and metastatic infantile fibrosarcoma harboring LMNA–NTRK1 fusion shows complete and durable response to crizotinib | Semantic Scholar PDF] Refractory and metastatic infantile fibrosarcoma harboring LMNA–NTRK1 fusion shows complete and durable response to crizotinib | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a18423da54475bbc4f0d5cdfb43a3bec6a9fce06/4-Figure3-1.png)
PDF] Refractory and metastatic infantile fibrosarcoma harboring LMNA–NTRK1 fusion shows complete and durable response to crizotinib | Semantic Scholar
![The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B–NTRK1 fusion | SpringerLink The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B–NTRK1 fusion | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10120-020-01061-9/MediaObjects/10120_2020_1061_Fig3_HTML.png)
The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B–NTRK1 fusion | SpringerLink
![Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target | Nature Communications Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms15987/MediaObjects/41467_2017_Article_BFncomms15987_Fig1_HTML.jpg)
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target | Nature Communications
![ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research - ScienceDirect ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419459929-gr1.jpg)